Obesity and metabolic syndrome: Potential benefit from specific nutritional components

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue SUPPL. 2, 2011, Pages

  Abete, I ^a   Goyenechea, E ^b   Zulet, M A ^a   Martinez J A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Colegio Oficial de Farmaceúticos ^*  (Spain)

Author keywords

Antioxidants; Dietary treatment; Metabolic syndrome; Minerals and vitamins; Obesity

Indexed keywords

ANTIOXIDANT; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; DIET; DIET THERAPY; DIETETICS; DYSLIPIDEMIA; FATTY LIVER; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; REVIEW; RISK FACTOR;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; DIETETICS; DYSLIPIDEMIAS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FATTY LIVER; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS;

EID: 80052404247     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.05.001     Document Type: Review

References (134)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
2. Bruce K.D., Hanson M.A. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010, 140:648-652.
3. Martinez M.A., Puig J.G., Mora M., Aragon R., O'Dogherty P., Anton J.L., et al. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) study. Metabolism 2008, 57:1232-1240.
4. Phillips C.M., Goumidi L., Bertrais S., Field M.R., Cupples L.A., Ordovas J.M., et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J Lipid Res 2010, 51:1793-1800.
5. Druet C., Ong K., Levy Marchal C. Metabolic syndrome in children: comparison of the International Diabetes Federation 2007 consensus with an adapted National Cholesterol Education Program definition in 300 overweight and obese French children. Horm Res Paediatr 2010, 73:181-186.
6. Pereira M.A., Kottke T.E., Jordan C., O'Connor P.J., Pronk N.P., Carreon R. Preventing and managing cardiometabolic risk: the logic for intervention. Int J Environ Res Public Health 2009, 6:2568-2584.
7. Muzio F., Mondazzi L., Harris W.S., Sommariva D., Branchi A. Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr 2007, 86:946-951.
8. Steemburgo T., Dall'Alba V., Gross J.L., Azevedo M.J. [Dietary factors and metabolic syndrome]. Arq Bras Endocrinol Metabol 2007, 51:1425-1433.
9. Vernaglione L. The Mediterranean diet: a matter of history, tradition, culture and health. J Nephrol 2009, 22(Suppl. 14):149-158.
10. Puchau B., Zulet M.A., de Echávarri A.G., Hermsdorff H.H., Martínez J.A. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 2010, 26:534-541.
11. Samman S., Koh H.S., Flood V.M., Blakesmith S.J., Petocz P., Lyons-Wall P.M. Red clover (Trifolium pratense) isoflavones and serum homocysteine in premenopausal women: a pilot study. J Womens Health (Larchmt) 2009, 18:1813-1816.
12. Campbell M.J., Woodside J.V., Honour J.W., Morton M.S., Leathem A.J. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 2004, 58:173-179.
13. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 2009, 101:886-894.
14. Devaraj S., Tang R., Adams-Huet B., Harris A., Seenivasan T., de Lemos J.A., et al. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007, 86:1392-1398.
15. Soory M. Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect Disord Drug Targets 2009, 9:400-414.
16. Malvy D.J., Favier A., Faure H., Preziosi P., Galan P., Arnaud J., et al. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study. Cancer Detect Prev 2001, 25:479-485.
17. Christen W.G., Gaziano J.M., Hennekens C.H. Design of Physicians' Health Study II - a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000, 10:125-134.
18. Catania A.S., de Barros C.R., Ferreira S.R. [Vitamins and minerals with antioxidant properties and cardiometabolic risk: controversies and perspectives]. Arq Bras Endocrinol Metabol 2009, 53:550-559.
19. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Hu F.B., Willett W.C. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr 2007, 98:807-813.
20. Bressan J., Hermsdorff H.H., Zulet M.A., Martinez J.A. [Hormonal and inflammatory impact of different dietetic composition: emphasis on dietary patterns and specific dietary factors]. Arq Bras Endocrinol Metabol 2009, 53:572-581.
21. Babio N., Bullo M., Basora J., Martinez-Gonzalez M.A., Fernandez-Ballart J., Marquez-Sandoval F., et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis 2009, 19:563-570.
22. Czernichow S., Vergnaud A.C., Galan P., Arnaud J., Favier A., Faure H., et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 2009, 90:329-335.
23. Spanou C., Stagos D., Aligiannis N., Kouretas D. Influence of potent antioxidant leguminosae family plant extracts on growth and antioxidant defense system of Hep2 cancer cell line. J Med Food 2010, 13:149-155.
24. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009, 102:1065-1074.
25. Cao G., Russell R.M., Lischner N., Prior R.L. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 1998, 128:2383-2390.
26. Kataja-Tuomola M., Sundell J.R., Mannisto S., Virtanen M.J., Kontto J., Albanes D., et al. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Diabetologia 2008, 51:47-53.
27. Clarke R., Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc Drugs Ther 2002, 16:411-415.
28. Wu J.H., Ward N.C., Indrawan A.P., Almeida C.A., Hodgson J.M., Proudfoot J.M., et al. Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem 2007, 53:511-519.
29. Crujeiras A.B., Parra M.D., Rodriguez M.C., Martinez de Morentin B.E., Martinez J.A. A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss. Nutrition 2006, 22:593-599.
30. Shenoy S.F., Poston W.S., Reeves R.S., Kazaks A.G., Holt R.R., Keen C.L., et al. Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial. Nutr J 2010, 9:8.
31. Bazzano L.A., Thompson A.M., Tees M.T., Nguyen C.H., Winham D.M. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2011, 21:94-103.
32. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007, 85:1148-1156.
33. Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005, 81:397-408.
34. Zhuo X.G., Melby M.K., Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr 2004, 134:2395-2400.
35. Crujeiras A.B., Parra D., Abete I., Martinez J.A. A hypocaloric diet enriched in legumes specifically mitigates lipid peroxidation in obese subjects. Free Radic Res 2007, 41:498-506.
36. Abete I., Parra D., Martinez J.A. Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response. Clin Nutr 2008, 27:545-551.
37. Rizkalla S.W., Bellisle F., Slama G. Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr 2002, 88(Suppl. 3):S255-S262.
38. Sadruddin S., Arora R. Resveratrol: biologic and therapeutic implications. J Cardiometab Syndr 2009, 4:102-106.
39. Zern T.L., Wood R.J., Greene C., West K.L., Liu Y., Aggarwal D., et al. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005, 135:1911-1917.
40. Rivera L., Moron R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009, 77:1053-1063.
41. Cacciapuoti F. Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin - resveratrol's role. Metab Syndr Relat Disord 2009, 7:397-400.
42. Bertelli A.A., Das D.K. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 2009, 54:468-476.
43. Liu L., Wang Y., Lam K.S., Xu A. Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications. Endocr Metab Immune Disord Drug Targets 2008, 8:89-98.
44. Micallef M., Lexis L., Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J 2007, 6:27.
45. Estruch R., Sacanella E., Mota F., Chiva-Blanch G., Antúnez E., Casals E., et al. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. Nutr Metab Cardiovasc Dis 2011, 21:46-53.
46. Noll C., Hamelet J., Ducros V., Belin N., Paul J.L., Delabar J.M., et al. Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice. Food Chem Toxicol 2009, 47:230-236.
47. Moore R.J., Jackson K.G., Minihane A.M. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 2009, 102:1790-1802.
48. Sirtori C.R., Galli C., Anderson J.W., Sirtori E., Arnoldi A. Functional foods for dyslipidaemia and cardiovascular risk prevention. Nutr Res Rev 2009, 22:244-261.
49. Ikeda I. Multifunctional effects of green tea catechins on prevention of the metabolic syndrome. Asia Pac J Clin Nutr 2008, 17(Suppl. 1):273-274.
50. Boon N. Health potential for functional green teas?. Int J Vitam Nutr Res 2008, 78:275-281.
51. Trinidad T.P., Mallillin A.C., Loyola A.S., Sagum R.S., Encabo R.R. The potential health benefits of legumes as a good source of dietary fibre. Br J Nutr 2009, 103:569-574.
52. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000, 71:412-433.
53. Anderson J.W. Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. Curr Atheroscler Rep 2000, 2:536-541.
54. Shai I., Schwarzfuchs D., Henkin Y., Shahar D.R., Witkow S., Greenberg I., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229-241.
55. Barclay A.W., Petocz P., McMillan-Price J., Flood V.M., Prvan T., Mitchell P., et al. Glycemic index, glycemic load, and chronic disease risk - a meta-analysis of observational studies. Am J Clin Nutr 2008, 87:627-637.
56. Scribner K.B., Pawlak D.B., Aubin C.M., Majzoub J.A., Ludwig D.S. Long-term effects of dietary glycemic index on adiposity, energy metabolism, and physical activity in mice. Am J Physiol Endocrinol Metab 2008, 295:E1126-E1131.
57. Kabir M., Rizkalla S.W., Quignard-Boulange A., Guerre-Millo M., Boillot J., Ardouin B., et al. A high glycemic index starch diet affects lipid storage-related enzymes in normal and to a lesser extent in diabetic rats. J Nutr 1998, 128:1878-1883.
58. Scribner K.B., Pawlak D.B., Ludwig D.S. Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. Obesity (Silver Spring) 2007, 15:2190-2199.
59. Brand-Miller J., McMillan-Price J., Steinbeck K., Caterson I. Carbohydrates - the good, the bad and the whole grain. Asia Pac J Clin Nutr 2008, 17(Suppl. 1):16-19.
60. de Rougemont A., Normand S., Nazare J.A., Skilton M.R., Sothier M., Vinoy S., et al. Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects. Br J Nutr 2007, 98:1288-1298.
61. Flint A., Moller B.K., Raben A., Sloth B., Pedersen D., Tetens I., et al. Glycemic and insulinemic responses as determinants of appetite in humans. Am J Clin Nutr 2006, 84:1365-1373.
62. Jenkins D.J., Kendall C.W., McKeown-Eyssen G., Josse R.G., Silverberg J., Booth G.L., et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
63. Leinonen K., Liukkonen K., Poutanen K., Uusitupa M., Mykkanen H. Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Eur J Clin Nutr 1999, 53:262-267.
64. Juntunen K.S., Laaksonen D.E., Autio K., Niskanen L.K., Holst J.J., Savolainen K.E., et al. Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread. Am J Clin Nutr 2003, 78:957-964.
65. Larsen T.M., Dalskov S.M., van Baak M., Jebb S.A., Papadaki A., Pfeiffer A.F., et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010, 363:2102-2113.
66. Corica F., Corsonello A., Ientile R., Cucinotta D., Di Benedetto A., Perticone F., et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 2006, 25:210-215.
67. Guerrero-Romero F., Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002, 39:209-213.
68. He K., Liu K., Daviglus M.L., Morris S.J., Loria C.M., Van Horn L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113:1675-1682.
69. McKeown N.M., Jacques P.F., Zhang X.L., Juan W., Sahyoun N.R. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr 2008, 47:210-216.
70. Guerrera M.P., Volpe S.L., Mao J.J. Therapeutic uses of magnesium. Am Fam Physician 2009, 80:157-162.
71. He K., Song Y., Belin R.J., Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 2006, 1:351-355.
72. Paolisso G., Passariello N., Pizza G., Marrazzo G., Giunta R., Sgambato S., et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol (Copenh) 1989, 121:16-20.
73. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003, 26:1147-1152.
74. Song Y., He K., Levitan E.B., Manson J.E., Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 2006, 23:1050-1056.
75. Astrup A., Kristensen M., Gregersen N.T., Belza A., Lorenzen J.K., Due A., et al. Can bioactive foods affect obesity?. Ann N Y Acad Sci 2010, 1190:25-41.
76. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 2000, 14:1132-1138.
77. Shahar D.R., Abel R., Elhayany A., Vardi H., Fraser D. Does dairy calcium intake enhance weight loss among overweight diabetic patients?. Diabetes Care 2007, 30:485-489.
78. Tremblay A., Gilbert J.A. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009, 28(Suppl. 1):91S-102S.
79. Lamarche B. Review of the effect of dairy products on non-lipid risk factors for cardiovascular disease. J Am Coll Nutr 2008, 27:741S-746S.
80. Lutsey P.L., Steffen L.M., Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008, 117:754-761.
81. Alonso A., Beunza J.J., Delgado-Rodriguez M., Martinez J.A., Martinez-Gonzalez M.A. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 2005, 82:972-979.
82. Alonso A., Zozaya C., Vazquez Z., Alfredo Martinez J., Martinez-Gonzalez M.A. The effect of low-fat versus whole-fat dairy product intake on blood pressure and weight in young normotensive adults. J Hum Nutr Diet 2009, 22:336-342.
83. van Meijl L.E., Vrolix R., Mensink R.P. Dairy product consumption and the metabolic syndrome. Nutr Res Rev 2008, 21:148-157.
84. Tholstrup T. Dairy products and cardiovascular disease. Curr Opin Lipidol 2006, 17:1-10.
85. Teegarden D., White K.M., Lyle R.M., Zemel M.B., Van Loan M.D., Matkovic V., et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 2008, 16:1566-1572.
86. Zemel M. Calcium modulation of adiposity. Obes Res 2003, 11:375-376.
87. Zemel M.B. Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 2009, 37:29-39.
88. Zemel M.B., Miller S.L. Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 2004, 62:125-131.
89. Zemel M.B. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001, 20:428S-435S. [Discussion 440S-442S].
90. Pfeuffer M., Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev 2007, 8:109-118.
91. Wennersberg M.H., Smedman A., Turpeinen A.M., Retterstol K., Tengblad S., Lipre E., et al. Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr 2009, 90:960-968.
92. Ganji V., Kafai M.R. Serum total homocysteine concentration determinants in non-Hispanic White, non-Hispanic Black, and Mexican-American populations of the United States. Ethn Dis 2004, 14:476-482.
93. Oshaug A., Bugge K.H., Refsum H. Diet, an independent determinant for plasma total homocysteine. A cross sectional study of Norwegian workers on platforms in the North Sea. Eur J Clin Nutr 1998, 52:7-11.
94. Zulet M.A., Puchau B., Hermsdorff H.H., Navarro C., Martinez J.A. Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults. Nutr Res 2009, 29:41-48.
95. Puchau B., Zulet M.A., Gonzalez de Echavarri A., Navarro-Blasco I., Martinez J.A. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults. Eur J Clin Nutr 2009, 63:858-864.
96. Singh R.B., Niaz M.A., Rastogi S.S., Bajaj S., Gaoli Z., Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998, 17:564-570.
97. Partida-Hernandez G., Arreola F., Fenton B., Cabeza M., Roman-Ramos R., Revilla-Monsalve M.C. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 2006, 60:161-168.
98. Song Y., Wang J., Li X.K., Cai L. Zinc and the diabetic heart. Biometals 2005, 18:325-332.
99. Lee K., Lee J., Bae W.K., Choi J.K., Kim H.J., Cho B. Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans - one high in protein and one nutritionally balanced. Int J Clin Pract 2009, 63:195-201.
100. Domingo J.L. Omega-3 fatty acids and the benefits of fish consumption: is all that glitters gold?. Environ Int 2007, 33:993-998.
101. Woodside J.V., Kromhout D. Fatty acids and CHD. Proc Nutr Soc 2005, 64:554-564.
102. Cicero A.F., Derosa G., Di Gregori V., Bove M., Gaddi A.V., Borghi C. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens 2010, 32:137-144.
103. Cicero A.F., Ertek S., Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 2009, 7:330-337.
104. Mori T.A., Burke V., Puddey I.B., Shaw J.E., Beilin L.J. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 2004, 22:1983-1990.
105. Abete I., Parra D., Crujeiras A.B., Goyenechea E., Martinez J.A. Specific insulin sensitivity and leptin responses to a nutritional treatment of obesity via a combination of energy restriction and fatty fish intake. J Hum Nutr Diet 2008, 21:591-600.
106. Marques M., Parra D., Kiely M., Bandarra N., Thorsdottir I., Martinez J.A. [Omega-3 fatty acids inclusion as part of an energy restricted diet to improve the effect on blood lipids]. Med Clin (Barc) 2008, 130:10-12.
107. Ebbesson S.O., Risica P.M., Ebbesson L.O., Kennish J.M. Eskimos have CHD despite high consumption of omega-3 fatty acids: the Alaska Siberia project. Int J Circumpolar Health 2005, 64:387-395.
108. Ebbesson S.O., Risica P.M., Ebbesson L.O., Kennish J.M., Tejero M.E. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health 2005, 64:396-408.
109. Ebbesson S.O., Tejero M.E., Nobmann E.D., Lopez-Alvarenga J.C., Ebbesson L., Romenesko T., et al. Fatty acid consumption and metabolic syndrome components: the GOCADAN study. J Cardiometab Syndr 2007, 2:244-249.
110. Mostad I.L., Bjerve K.S., Basu S., Sutton P., Frayn K.N., Grill V. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus. Metabolism 2009, 58:1753-1761.
111. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 2001, 44:312-319.
112. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
113. Erkkila A.T., Schwab U.S., de Mello V.D., Lappalainen T., Mussalo H., Lehto S., et al. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr 2008, 47:319-328.
114. Thorsdottir I., Tomasson H., Gunnarsdottir I., Gisladottir E., Kiely M., Parra M.D., et al. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 2007, 31:1560-1566.
115. Buckley J.D., Howe P.R. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 2009, 10:648-659.
116. Fito M., de la Torre R., Covas M.I. Olive oil and oxidative stress. Mol Nutr Food Res 2007, 51:1215-1224.
117. Paniagua J.A., de la Sacristana A.G., Sanchez E., Romero I., Vidal-Puig A., Berral F.J., et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 2007, 26:434-444.
118. Martinez-Gonzalez M.A., Bes-Rastrollo M. The cardioprotective benefits of monounsaturated fatty acid. Altern Ther Health Med 2006, 12:24-30. quiz 31.
119. Perez-Jimenez F., Ruano J., Perez-Martinez P., Lopez-Segura F., Lopez-Miranda J. The influence of olive oil on human health: not a question of fat alone. Mol Nutr Food Res 2007, 51:1199-1208.
120. Covas M.I., Nyyssonen K., Poulsen H.E., Kaikkonen J., Zunft H.J., Kiesewetter H., et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 2006, 145:333-341.
121. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 2009, 89:1649S-1656S.
122. Casas-Agustench P., López-Uriarte P., Bulló M., Ros E., Cabré-Vila J.J., Salas-Salvadó J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2011, 21:126-135.
123. Phung O.J., Makanji S.S., White C.M., Coleman C.I. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc 2009, 109:865-873.
124. Li T.Y., Brennan A.M., Wedick N.M., Mantzoros C., Rifai N., Hu F.B. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 2009, 139:1333-1338.
125. Bes-Rastrollo M., Sabate J., Gomez-Gracia E., Alonso A., Martinez J.A., Martinez-Gonzalez M.A. Nut consumption and weight gain in a Mediterranean cohort: the SUN study. Obesity (Silver Spring) 2007, 15:107-116.
126. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000, 102:2284-2299.
127. Ryan E., Galvin K., O'Connor T.P., Maguire A.R., O'Brien N.M. Fatty acid profile, tocopherol, squalene and phytosterol content of brazil, pecan, pine, pistachio and cashew nuts. Int J Food Sci Nutr 2006, 57:219-228.
128. McBride P.E., Einerson J.A., Grant H., Sargent C., Underbakke G., Vitcenda M., et al. Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. J Nutr Health Aging 2008, 12:745S-749S.
129. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005, 28:2823-2831.
130. Lindstrom J., Absetz P., Hemio K., Peltomaki P., Peltonen M. Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland. Public Health Nutr 2010, 13:993-999.
131. Parra D., Bandarra N.M., Kiely M., Thorsdottir I., Martinez J.A. Impact of fish intake on oxidative stress when included into a moderate energy-restricted program to treat obesity. Eur J Nutr 2007, 46:460-467.
132. Ramel A., Parra D., Martinez J.A., Kiely M., Thorsdottir I. Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults. Eur J Nutr 2009, 48:107-114.
133. Rodriguez M.C., Parra M.D., Marques-Lopes I., De Morentin B.E., Gonzalez A., Martinez J.A. Effects of two energy-restricted diets containing different fruit amounts on body weight loss and macronutrient oxidation. Plant Foods Hum Nutr 2005, 60:219-224.
134. Razquin C., Martinez J.A., Martinez-Gonzalez M.A., Mitjavila M.T., Estruch R., Marti A. A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain. Eur J Clin Nutr 2009, 63:1387-1393.